Roberts, Glore & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Buy |
20,599
+9,510
| +86% | +$656K | 0.42% | 61 |
|
|
2025
Q1 | $770K | Buy |
11,089
+7,946
| +253% | +$552K | 0.23% | 95 |
|
|
2024
Q4 | $270K | Sell |
3,143
-62
| -2% | -$5.33K | 0.08% | 176 |
|
|
2024
Q3 | $382K | Sell |
3,205
-225
| -7% | -$26.8K | 0.11% | 146 |
|
|
2024
Q2 | $490K | Hold |
3,430
| – | – | 0.15% | 122 |
|
|
2024
Q1 | $440K | Sell |
3,430
-100
| -3% | -$12.8K | 0.13% | 131 |
|
|
2023
Q4 | $365K | Sell |
3,530
-138
| -4% | -$14.3K | 0.11% | 137 |
|
|
2023
Q3 | $334K | Sell |
3,668
-122
| -3% | -$11.1K | 0.11% | 140 |
|
|
2023
Q2 | $307K | Buy |
3,790
+46
| +1% | +$3.72K | 0.1% | 154 |
|
|
2023
Q1 | $298K | Sell |
3,744
-60
| -2% | -$4.77K | 0.1% | 151 |
|
|
2022
Q4 | $257K | Buy |
+3,804
| New | +$257K | 0.09% | 158 |
|
|
2022
Q3 | – | Sell |
-4,004
| Closed | -$223K | – | 189 |
|
|
2022
Q2 | $223K | Hold |
4,004
| – | – | 0.07% | 173 |
|
|
2022
Q1 | $222K | Sell |
4,004
-1,600
| -29% | -$88.7K | 0.06% | 190 |
|
|
2021
Q4 | $314K | Hold |
5,604
| – | – | 0.08% | 157 |
|
|
2021
Q3 | $269K | Hold |
5,604
| – | – | 0.08% | 160 |
|
|
2021
Q2 | $235K | Buy |
+5,604
| New | +$235K | 0.07% | 175 |
|